Evidence map›Paper›PMID 19609968›Full record

ArticleProteomics2009

Chronic ethanol feeding affects proteasome-interacting proteins.

Marie-Pierre Bousquet-Dubouch, Sheila Nguen, David Bouyssié, Odile Burlet-Schiltz, Samuel W French, Bernard Monsarrat, Fawzia Bardag-Gorce

Abstract read
In one paragraph

Article in Proteomics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Cirrhosis and Sarcopenia.Seminars in interventional radiology · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Proteasome assembly.Cellular and molecular life sciences : CMLS · 2014
    Review
  10. Review
  11. Article
  12. Article
  13. Recent advances in quantitative neuroproteomics.Methods (San Diego, Calif.) · 2013
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Proteasome inhibitor treatment in alcoholic liver disease.World journal of gastroenterology · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marie-Pierre Bousquet-DubouchCNRS, Institut de Pharmacologie et de Biologie Structurale, Toulouse, France. marie-pierre.bousquet@ipbs.fr
Sheila Nguen
David Bouyssié
Odile Burlet-Schiltz
Samuel W French
Bernard Monsarrat
Fawzia Bardag-Gorce

Funding

PATHOGENESIS OF EXPERIMENTAL ALCOHOLIC LIVER DISEASER01AA008116 · NIAAA · UNIVERSITY OF OTTAWA · PI FRENCH, SAMUEL WILLIAM · 1990 to 2010
$2.9M
NIAAA NIH HHS R01 AA008116PHS HHS 008116PHS HHS P50-011999
6 · The paper itself

Abstract

Studies on alcoholic liver injury mechanisms show a significant inhibition of the proteasome activity. To investigate this phenomenon, we isolated proteasome complexes from the liver of rats fed ethanol chronically, and from the liver of their pair-fed controls, using a non-denaturing multiple centrifugations procedure to preserve proteasome-interacting proteins (PIPs). ICAT and MS/MS spectral counting, further confirmed by Western blot, showed that the levels of several PIPs were significantly decreased in the isolated ethanol proteasome fractions. This was the case of PA28alpha/beta proteasome activator subunits, and of three proteasome-associated deubiquitinases, Rpn11, ubiquitin C-terminal hydrolase 14, and ubiquitin carboxyl-terminal hydrolase L5. Interestingly, Rpn13 C-terminal end was missing in the ethanol proteasome fraction, which probably altered the linking of ubiquitin carboxyl-terminal hydrolase L5 to the proteasome. 20S proteasome and most 19S subunits were however not changed but Ecm29, a protein known to stabilize the interactions between the 20S and its activators, was decreased in the isolated ethanol proteasome fractions. It is proposed that ethanol metabolism causes proteasome inhibition by several mechanisms, including by altering PIPs and proteasome regulatory complexes binding to the proteasome.

Indexed as

Amino Acid SequenceAnimalsCatalytic DomainCytochrome P-450 CYP2E1EthanolLiverMaleMembrane GlycoproteinsMolecular Sequence DataProteasome Endopeptidase ComplexRatsRats, WistarTandem Mass SpectrometryCytochrome P-450 CYP2E1EthanolMembrane GlycoproteinsProteasome Endopeptidase Complex

Identifiers

PMID19609968
PMCPMC2766596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.